Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity
- PMID: 32275971
- PMCID: PMC7138381
- DOI: 10.1016/j.metabol.2020.154224
Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity
Keywords: COVID-19; Corticosteroid; Diabetes; Risk; Telemedicine.
Conflict of interest statement
Declaration of competing interest D.C.K. is a consultant for Abbott, Ascensia, Dexcom EOFlow, Fractyl, Lifecare, Novo Nordisk, Roche, and Thirdwayv. G.E.U. has received unrestricted research support for inpatient studies (to Emory University) from Dexcom.
Comment on
-
Commentary: COVID-19 in patients with diabetes.Metabolism. 2020 Jun;107:154217. doi: 10.1016/j.metabol.2020.154217. Epub 2020 Mar 24. Metabolism. 2020. PMID: 32220611 Free PMC article. No abstract available.
References
-
- Yang J.K., Feng Y., Yuan M.Y., Yuan S.Y., Fu H.J., Wu B.Y. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006 Jun;23(6):623–628. - PubMed
-
- Klonoff D.C., Blonde L., Cembrowski G., Chacra A.R., Charpentier G., Colagiuri S. Coalition for clinical research-self-monitoring of blood glucose scientific board. Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol. 2011;5(6):1529–1548. Nov 1. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical